Ledger.Open graph →
SEC Form D · Amendment · filed August 25, 2011

INTARCIA THERAPEUTICS, INC

Offering
$44.0M
Sold
$40.3M
Exemption
Industry
Pharmaceuticals
Location
HAYWARD, CA
Type

People & firms on this filing (24)

Glen Sato · Palo Alto, CADirectorThomas R. Alessi · Hayward, CAExecBarbara G. Mcclung · Hayward, CAExecKurt Graves · Hayward, CADirectorDavid J. Franklin · Hayward, CAExecEd Mathers · Chevy Chase, MDDirectorK. A. Leung · Hayward, CAExec · DirectorBryan E. Roberts · Palo Alto, CADirectorJames Niedel · New York, NYDirectorJames M. Ahlers · Hayward, CAExecIrwin Scher · Gaithersburg, MDDirectorKenneth L. Luskey · Hayward, CAExecIan Pilgram · Grand Cayman, Cayman IslandsExec · DirectorMartin Byrne · Grand Cayman, Cayman IslandsExecWilliam Park · Stamford, CTExecAcp Offshore General Partner Ii, Ltd · GRAND CAYMAN, Cayman IslandsExecDoug Burton · Orinda, CADirectorRobert C. Lewis · Atlanta, GAExecBrookfield Investment Management Inc · New York, NYDirectorJeremy Rowland · CRESTONE, COExecPhilippe R. Chambon · New Haven, CTDirectorMarc N. Lampert · San Francisco, CADirectorMatthew D. Perry · San Francisco, CADirectorOleg Nodelman · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗